Correlation Between Unicycive Therapeutics and Seres Therapeutics
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Seres Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Seres Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Seres Therapeutics, you can compare the effects of market volatilities on Unicycive Therapeutics and Seres Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Seres Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Seres Therapeutics.
Diversification Opportunities for Unicycive Therapeutics and Seres Therapeutics
-0.09 | Correlation Coefficient |
Good diversification
The 3 months correlation between Unicycive and Seres is -0.09. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Seres Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Seres Therapeutics and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Seres Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Seres Therapeutics has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Seres Therapeutics go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Seres Therapeutics
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 0.67 times more return on investment than Seres Therapeutics. However, Unicycive Therapeutics is 1.49 times less risky than Seres Therapeutics. It trades about 0.38 of its potential returns per unit of risk. Seres Therapeutics is currently generating about 0.21 per unit of risk. If you would invest 53.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 27.00 from holding Unicycive Therapeutics or generate 50.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 95.45% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Seres Therapeutics
Performance |
| Timeline |
| Unicycive Therapeutics |
| Seres Therapeutics |
Unicycive Therapeutics and Seres Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Seres Therapeutics
The main advantage of trading using opposite Unicycive Therapeutics and Seres Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Seres Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Seres Therapeutics will offset losses from the drop in Seres Therapeutics' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Seres Therapeutics vs. Syros Pharmaceuticals | Seres Therapeutics vs. Iovance Biotherapeutics | Seres Therapeutics vs. Veracyte | Seres Therapeutics vs. Fate Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Financial Widgets module to easily integrated Macroaxis content with over 30 different plug-and-play financial widgets.
Other Complementary Tools
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital |